CLINICAL_TRIALS
trial_result
· 2012-12-21
Clinical Trial Update: Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome [Phase 2]
Summary
A Phase 2 trial evaluating azacitidine plus amifostine in patients with myelodysplastic syndromes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Michigan Rogel Cancer Center | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED